What makes Xstrahl unique in the world of radiation? Hear from our CEO, Adrian Treverton on how Xstrahl connects leading researchers and clinicians, and paves the way for radiation innovation with our incredible team. https://vimeo.com/716514378
Hear from Xstrahl's CEO, Adrian Treverton and Technical Service Manager, Wilfried Goetz about increasing throughput in SARRP research with a variety of mouse beds. Radiation research can be done on multiple subjects at once. https://youtu.be/Hx0oUJ8kkxU
In the study, Radiotherapy-exposed CD8+ and CD4+ Neoantigens Enhance Tumor Control, SARRP enabled researchers to verify that radiotherapy works in concert with neoantigen vaccination to improve tumor control. See more below, and the full study here.
Hear from our Chief Scientific Officer, Amanda Tulk, about recent case studies by Dr. Gerald Fogarty. Dr. Fogarty used superficial radiotherapy to treat lesions of the ear, lips and eyelids. https://vimeo.com/718008005
Oncology is one of the main growing specialties in small animal medicine with a high number of cases and wider availability of CT scanning. Radiation therapy is part of numerous cancer treatment protocols but still mostly unavailable. Orthovoltage radiation provides a...
The majority of radiobiology studies follow a classic linear research pathway — from laboratory-based research to preclinical studies that can lead to clinical trials. Researchers at Queen’s University Belfast are beginning to challenge this approach by reverse...
In this video with our Chief Scientific Officer, Amanda Tulk, you can learn about some of the important pieces of setting up a good radiotherapy skin practice and see how Dr. Gerald Fogarty has been able to successfully treat a range of patients....
It can be difficult to treat non-melanoma skin cancer (NMSC) of the lower legs. The blood supply of the lower legs makes surgery challenging, and radiotherapy below the knee is controversial because of the fear of radiation-induced ulcers. In the study, "Lesion-based...
Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short...
Contact Us